Overview
Kaléo is a leader in auto-injector innovation, leveraging its patented Aerio™ platform and human factors engineering expertise to help advance public access emergency preparedness. Our technology powers drug-delivery solutions designed to support appropriate use during severe allergic reactions. Through efforts across community settings, Kaléo is helping to broaden access to emergency response solutions and to increase readiness where allergic emergencies may occur.
Kaléo is a pharmaceutical company that builds solutions that can help empower patients with certain serious, life-threatening medical conditions and their caregivers.